Citations

Clear

6273 citation(s) found for "To, Andrew".

Specific renal parenchymal‐derived urinary extracellular vesicles identify age‐associated structural changes in living donor kidneys
Turco, Anne E. , Lam, Wing Yan, Đenić, Aleksandar , Miller, Virginia M. , Larson, Joseph J. , Kremers, Walter K. , Jayachandran, Muthuvel , Lam, Wing, Lam, Wing, Rule, Andrew D. , Lieske, John C. , Denic, Aleksandar , Kremers, Walter K

Mayo Clinic

Journal of Extracellular Vesicles | February 1, 2016 | Volume: 5 | Issue: 1 | Pages: No page available

10.3402/jev.v5.29642 | PMID 26837814 Get It

Non‐invasive tests to identify age and early disease‐associated pathology within the kidney are needed. Specific populations of urinary extracellular vesicles (EVs) could potentially be used for such a diagnostic test. Random urine samples were obtained from age‐ and sex‐stratified living kidney donors before kidney donation. A biopsy of the donor kidney was obtained at the time of transplantation to identify nephron hypertrophy (larger glomerular volume, cortex per glomerulus and mean profile tubular area) and nephrosclerosis (% fibrosis, % glomerulosclerosis and arteriosclerosis). Renal parenchymal‐derived EVs in cell‐free urine were quantified by digital flow cytometry. The relationship between these EV populations and structural pathology on the kidney biopsy was assessed. Clinical characteristics of the kidney donors (n=138, age range: 20–70 years, 50% women) were within the normative range. Overall, urine from women contained more EVs than that from men. The number of exosomes, juxtaglomerular cells and podocyte marker–positive EVs decreased (p<0.05) with increasing age. There were fewer total EVs as well as EVs positive for mesangial cell, parietal cell, descending limb of Henle's loop (simple squamous epithelium), collecting tubule‐intercalated cell and monocyte chemoattractant protein‐1 markers (p<0.05) in persons with nephron hypertrophy. The number of EVs positive for intercellular adhesion molecule‐1, juxtaglomerular cell, podocyte, parietal cell, proximal tubular epithelial cell, distal tubular epithelial cell and collecting duct cells were fewer (p<0.05) in persons with nephrosclerosis. EVs carrying markers of cells from the renal pelvis epithelium did not associate with any indices of nephron hypertrophy or nephrosclerosis. Therefore, specific populations of EVs derived from cells of the glomerulus and nephron associate with underlying kidney structural changes. Further validation of these findings in other cohorts is needed to determine their clinical utility.
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
Group, Australian Ovarian Cancer Study, Study, Australian Cancer, Johnatty, Sharon E. , Lu, Yi , Beesley, Jonathan, Gao, Bo , Kalimutho, Murugan , Henderson, Michelle J. , Russell, Amanda J. , Kar, Siddhartha , Chen, Xiaoqing, Hillman, Kristine M. , Kaufmann, Susanne, Sivakumaran, Haran , O’Reilly, Martin, Wang, Chen , Korbie, Darren , Lambrechts, Diether , Despierre, Evelyn, Nieuwenhuysen, Els Van , Lambrechts, Sandrina, Vergote, Ignace , Lester, Jenny, Oršulić, Sandra , Walsh, Christine M. , Fasching, Peter A. , Beckmann, Matthias W. , Ekici, Arif B. , Hein, Alexander , Matsuo, Keitaro , Hosono, Satoyo , Pisterer, Jacobus, Hillemanns, Peter , Nakanishi, Toru , Yatabe, Yasushi , Goodman, Marc T. , Lurie, Galina, Matsuno, Rayna K., Thompson, Pamela J., Bean, Yukie T., Heitz, Florian , Harter, Philipp , Schwaab, Ira, Høgdall, Estrid , Jensen, Allan , Høgdall, Claus , Lundvall, Lene, Engelholm, Svend Aage, Brown, Bob, Flanagan, James M. , Metcalf, Michelle, Sellers, Thomas A. , Cunningham, Julie M. , Schildkraut, Joellen M. , Iversen, Ed , Weber, Rachel Palmieri , Brennan, Donal J. , Harnett, Paul R. , Haber, Michelle , Goode, Ellen L. , Lee, Jason S. , Khanna, Kum Kum , Meyer, Kerstin B. , Chenevix‐Trench, Georgia , DeFazio, Anna , Edwards, Stacey L. , MacGregor, Stuart , Brown, Robert , Lambrechts, Diether , Cunningham, Julie, Fazio, Anna de , French, Juliet D. , Group, Australian Ovarian Cancer Study, Study, Australian Cancer, Beesley, Jonathan, Chen, Xiaoqing, Karlan, Beth Y. , Pejovic, Tanja B. , Bois, Andreas du , Kjær, Susanne K. , Brown, Bob, Siddiqui, Nadeem , Fridley, Brooke L. , Berchuck, Andrew , Pharoah, Paul D.P. , Norris, Murray D , Lambrechts, Diether , Hein, Alexander , Hillemanns, Peter , Jensen, Allan , Haber, Michelle , Wang, Chen , Brown, Robert , Matsuo, Keitaro , Flanagan, James M , Heitz, Florian , Lambrechts, Diether , Ekici, Arif B , Lu, Yi , MacGregor, Stuart , Chenevix-Trench, Georgia , Høgdall, Estrid , Høgdall, Claus K , Kar, Siddhartha , Harnett, Paul R , Goodman, Marc T

Mayo Clinic

Oncotarget | January 31, 2016 | Volume: 7 | Issue: 6 | Pages: 6353-6368

10.18632/oncotarget.7047 | PMID 26840454 Get It

Adult-onset respiratory insufficiency, scoliosis, and distal joint hyperlaxity in patients with multiminicore disease due to novel Megf10 mutations
Liewluck, Teerin , Milone, Margherita , Xia, Tian , Engel, Andrew G. , Staff, Nathan P. , Wong, Lee-Jun, Liewluck, T , Staff, Nathan P

Mayo Clinic

Muscle & Nerve | January 23, 2016 | Volume: 53 | Issue: 6 | Pages: 984-988

10.1002/mus.25054 | PMID 26802438 Get It

P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments
Zalewski, Nicholas L. , Lennon, Vanda A. , Klein, Christopher J. , Pittock, Sean J. , McKeon, Andrew , Pittock, S J , Lachance, Daniel Honore , Klein, Christopher J , McKeon, Andrew

Mayo Clinic

Muscle & Nerve | January 20, 2016 | Volume: 54 | Issue: 2 | Pages: 220-227

10.1002/mus.25027 | PMID 26789908 Get It

Exudative Macular Detachment After Viral Illness With Rash
Maxfield, Steven D., Barkmeier, Andrew J.

Mayo Clinic

JAMA Ophthalmology | January 11, 2016 | Volume: 134 | Issue: 3 | Pages: 335

10.1001/jamaophthalmol.2015.3585 | PMID 26747787 Get It

Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer
Winham, Stacey J. , Pirie, Ailith, Chen, Y. Ann , Fogarty, Zachary C. , Earp, Madalene A. , Goodman, Marc T. , Levine, Douglas A. , Menon, Usha , Ness, Roberta B., Pearce, Celeste Leigh, Rossing, Mary Anne, Wentzensen, Nicolas , Bean, Yukie T., Bisogna, Maria, Brinton, Louise A. , Carney, Michael E. , Cunningham, Julie M. , DeFazio, Anna , Dicks, Ed , Edwards, Robert P., Gayther, Simon A. , Gore, Martin, Iversen, Edwin S., Jensen, Allan , Johnatty, Sharon E., Lester, Jenny, Lin, Hui‐Yi , Lissowska, Jolanta , Lubiński, Jan , Menkiszak, Janusz , Moysich, Kirsten B. , Pike, Malcolm C. , Ramus, Susan J. , Song, Honglin , Terry, Kathryn L. , Thompson, Pamela J., Berg, David J. van den , Vierkant, Robert A. , Vitonis, Allison F., Walsh, Christine M. , Wu, Anna H. , Group, Georgia Chenevix-Trench on behalf of Australian Ovarian Cancer Study, Schildkraut, Joellen M. , Permuth‐Wey, Jennifer, Phelan, Catherine M., Sellers, Thomas A. , Goode, Ellen L. , Webb, Penelope M. , Whiteman, David C. , Chenevix‐Trench, Georgia , Bowtell, David D.L. , Ewing, Ailith , Fazio, Anna de , Larson, Melissa C. , Anton‐Culver, Hoda , Bandera, Elisa V. , Cramer, Daniel W. , Doherty, Jennifer A. , Gronwald, Jacek , Karlan, Beth Y. , Kjær, Susanne K. , Pejovic, Tanja B. , Cybulski, Cezary , Gentry‐Maharaj, Aleksandra , Modugno, Francesmary , Orlow, Irene , Tyrer, Jonathan P. , Wilkens, Lynne R. , Yang, Hannah , Ziogas, Argyrios , Berchuck, Andrew , Group, Georgia Chenevix-Trench on behalf of Australian Ovarian Cancer Study, Pharoah, Paul D.P. , Fridley, Brooke L. , Winham, Stacey J , Ramus, Susan J , Webb, Penelope M , Jensen, Allan , Vierkant, Robert A , Menon, Usha , Moysich, Kirsten , Lissowska, Jolanta , Menkiszak, Janusz , Lin, Hui-Yi , Fogarty, Zachary C , Ewing, Ailith , Chenevix-Trench, Georgia , Whiteman, David C , Bowtell, David D , Lubinski, Jan , Goodman, Marc T

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 8, 2016 | Volume: 25 | Issue: 3 | Pages: 446-454

10.1158/1055-9965.epi-15-0240 | PMID 26747452 Get It

Abstract Background: While numerous susceptibility loci for epithelial ovarian cancer (EOC) have been identified, few associations have been reported with overall survival. In the absence of common prognostic genetic markers, we hypothesize that rare coding variants may be associated with overall EOC survival and assessed their contribution in two exome-based genotyping projects of the Ovarian Cancer Association Consortium (OCAC). Methods: The primary patient set (Set 1) included 14 independent EOC studies (4,293 patients) and 227,892 variants, and a secondary patient set (Set 2) included six additional EOC studies (1,744 patients) and 114,620 variants. Because power to detect rare variants individually is reduced, gene-level tests were conducted. Sets were analyzed separately at individual variants and by gene, and then combined with meta-analyses (73,203 variants and 13,163 genes overlapped). Results: No individual variant reached genome-wide statistical significance. A SNP previously implicated to be associated with EOC risk and, to a lesser extent, survival, rs8170, showed the strongest evidence of association with survival and similar effect size estimates across sets (Pmeta = 1.1E−6, HRSet1 = 1.17, HRSet2 = 1.14). Rare variants in ATG2B, an autophagy gene important for apoptosis, were significantly associated with survival after multiple testing correction (Pmeta = 1.1E−6; Pcorrected = 0.01). Conclusions: Common variant rs8170 and rare variants in ATG2B may be associated with EOC overall survival, although further study is needed. Impact: This study represents the first exome-wide association study of EOC survival to include rare variant analyses, and suggests that complementary single variant and gene-level analyses in large studies are needed to identify rare variants that warrant follow-up study. Cancer Epidemiol Biomarkers Prev; 25(3); 446–54. ©2016 AACR.
Associations between attending physician workload, teaching effectiveness, and patient safety
Wingo, Majken T. , Halvorsen, Andrew J. , Beckman, Thomas J. , Johnson, Matthew G. , Reed, Darcy A.

Mayo Clinic

Journal of Hospital Medicine | January 7, 2016 | Volume: 11 | Issue: 3 | Pages: 169-173

10.1002/jhm.2540 | PMID 26741703 Get It

BACKGROUNDPrior studies suggest that high workload among attending physicians may be associated with reduced teaching effectiveness and poor patient outcomes, but these relationships have not been investigated using objective measures of workload and safety.OBJECTIVETo examine associations between attending workload, teaching effectiveness, and patient safety, hypothesizing that higher workload would be associated with lower teaching effectiveness and negative patient outcomes.DESIGN, SETTING, AND PARTICIPANTSWe conducted a retrospective study of 69,386 teaching evaluation items submitted by 543 internal medicine residents for 107 attending physicians who supervised inpatient teaching services from July 2, 2005 to July 1, 2011.MEASUREMENTSAttending workload measures included hospital service census, patient length of stay, daily admissions, daily discharges, and concurrent outpatient duties. Teaching effectiveness was measured using residents' evaluations of attendings. Patient outcomes considered were applicable patient safety indicators (PSIs), intensive care unit transfers, cardiopulmonary resuscitation/rapid response team calls, and patient deaths. Mixed linear models and generalized linear regression models were used for statistical analysis.RESULTSWorkload measures of midnight census and daily discharges were associated with lower teaching evaluation scores (both β = −0.026, P < 0.0001). The number of daily admissions was associated with higher teaching scores (β = 0.021, P = 0.001) and increased PSIs (odds ratio = 1.81, P = 0.0001).CONCLUSIONSeveral measures of attending physician workload were associated with slightly lower teaching effectiveness, and patient safety may be compromised when teams are managing new admissions. Ongoing efforts by residency programs to optimize the learning environment should include strategies to manage the workload of supervising attendings. Journal of Hospital Medicine 2016;11:169–173. © 2016 Society of Hospital Medicine
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, Thomas, Gimona, Mario , Aigner, Ludwig , Börger, Verena , Buzás, Edit I. , Camussi, Giovanni , Chaput, Nathalie , Chatterjee, Devasis, Court, Felipe A. , Portillo, Hernando A. del , Fais, Stefano , Felderhoff‐Mueser, Ursula, Fraile, Lorenzo , Gho, Yong Song , Görgens, André , Gupta, Ramesh C. , Hendrix, An , Hill, Andrew F. , Hochberg, Fred H. , Horn, Peter A. , Kramer, Boris W. , Krämer‐Albers, Eva‐Maria , Laner‐Plamberger, Sandra , Laitinen, Saara , Leonardi, Tommaso , Lorenowicz, Magdalena J. , Lim, Sai Kiang , Lötvall, Jan , Maguire, Casey A. , Marcilla, Antonio , Nazarenko, Irina , Ochiya, Takahiro , Pedersen, Shona , Pòcsfalvi, Gabriella , Quesenberry, Peter J. , Reischl, Ilona , Rivera, Francisco J. , Sanzenbacher, Ralf, Schallmoser, Katharina , Slaper‐Cortenbach, Ineke , Strunk, Dirk , Vader, Pieter , Balkom, Bas W. M. van , Wauben, Marca H. M. , Andaloussi, Samir EL , Théry, Clotilde , Rohde, Eva , Giebel, Bernd , O’Driscoll, Lorraine , Falcón‐Pérez, Juan Manuel , Hermann, Dirk Matthias , Kleijn, Dominique P.V. de , Kordelas, Lambros , Patel, Tushar , Pluchino, Stefano , Tonn, Torsten , Leonardi, Tommaso , Nazarenko, Irina , Hill, Andrew F , Buzas, Edit I , Giebel, Bernd

Mayo Clinic

Journal of Extracellular Vesicles | December 31, 2015 | Volume: 4 | Issue: 1 | Pages: No page available

10.3402/jev.v4.30087 | PMID 26725829 Get It

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different cell types and participate in physiological and pathophysiological processes. EVs mediate intercellular communication as cell‐derived extracellular signalling organelles that transmit specific information from their cell of origin to their target cells. As a result of these properties, EVs of defined cell types may serve as novel tools for various therapeutic approaches, including (a) anti‐tumour therapy, (b) pathogen vaccination, (c) immune‐modulatory and regenerative therapies and (d) drug delivery. The translation of EVs into clinical therapies requires the categorization of EV‐based therapeutics in compliance with existing regulatory frameworks. As the classification defines subsequent requirements for manufacturing, quality control and clinical investigation, it is of major importance to define whether EVs are considered the active drug components or primarily serve as drug delivery vehicles. For an effective and particularly safe translation of EV‐based therapies into clinical practice, a high level of cooperation between researchers, clinicians and competent authorities is essential. In this position statement, basic and clinical scientists, as members of the International Society for Extracellular Vesicles (ISEV) and of the European Cooperation in Science and Technology (COST) program of the European Union, namely European Network on Microvesicles and Exosomes in Health and Disease (ME‐HaD), summarize recent developments and the current knowledge of EV‐based therapies. Aspects of safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application are highlighted. Production and quality control processes are discussed. Strategies to promote the therapeutic application of EVs in future clinical studies are addressed.
In Reply
Nakhleh, Raouf E. , Nosé, Vânia , Renshaw, Andrew A. , McCrory, Doug, Fatheree, Lisa A.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | December 30, 2015 | Volume: 140 | Issue: 1 | Pages: 9-10

10.5858/arpa.2015-0293-le | PMID 26717052 Get It